• 1. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 2. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 3. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 4. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 5. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212

Comprehensive Overview of 3-Iodothyroacetic Acid (CAS No. 60578-17-8): Properties, Applications, and Research Insights

3-Iodothyroacetic Acid (CAS No. 60578-17-8), a derivative of thyroacetic acid, is a biologically active compound with significant relevance in endocrine research and pharmaceutical development. This iodinated analog has garnered attention for its potential role in modulating thyroid hormone pathways, making it a subject of interest for researchers exploring metabolic disorders, neurodegenerative diseases, and cancer therapeutics. The compound's unique structure, featuring an iodine atom at the 3-position of the thyroacetic acid backbone, contributes to its distinct biochemical properties and interactions with thyroid hormone receptors.

In recent years, the scientific community has increasingly focused on thyroid hormone analogs like 3-Iodothyroacetic Acid due to their potential therapeutic applications. With growing public awareness about thyroid health—evidenced by rising searches for terms like "thyroid hormone metabolism" and "natural thyroid regulators"—this compound's significance extends beyond academic circles. Its mechanism of action, which differs from classical thyroid hormones, offers novel avenues for drug development, particularly in addressing conditions where traditional thyroid therapies prove insufficient.

The physicochemical properties of 3-Iodothyroacetic Acid (CAS No. 60578-17-8) contribute to its research utility. With a molecular weight of 332.07 g/mol and the characteristic iodine moiety, this compound exhibits specific solubility patterns and stability profiles that researchers must consider during experimental design. These properties make it particularly valuable in studies investigating thyroid hormone transport across cellular membranes and its subsequent metabolism—a hot topic in current endocrinology research, as evidenced by frequent searches for "thyroid hormone cell uptake mechanisms."

Current research trends highlight 3-Iodothyroacetic Acid's potential in neuroprotection studies. The compound's ability to influence neuronal metabolism without the side effects associated with traditional thyroid hormones has sparked interest in its application for neurodegenerative disorders—a field experiencing exponential growth due to aging populations worldwide. This aligns with increasing public searches for "natural neuroprotective agents" and "thyroid-brain connection," demonstrating how basic research compounds like this intersect with mainstream health concerns.

From a biochemical perspective, 3-Iodothyroacetic Acid (CAS No. 60578-17-8) interacts with both nuclear thyroid hormone receptors and membrane integrin receptors, creating a unique dual mechanism of action. This property has made it particularly valuable in studies exploring non-genomic thyroid hormone signaling—a rapidly evolving field that challenges traditional understanding of endocrine regulation. Researchers frequently investigate how this compound's effects differ from thyroxine (T4) and triiodothyronine (T3), especially in tissues where classical thyroid hormone action is limited.

The compound's role in metabolic regulation has gained prominence with increasing global focus on metabolic syndrome and obesity-related disorders. Unlike conventional thyroid hormones, 3-Iodothyroacetic Acid appears to influence lipid metabolism and energy expenditure through distinct pathways, making it a candidate for developing targeted metabolic therapies without the cardiovascular risks associated with thyroid hormone overstimulation. This application potential aligns with trending searches for "safe metabolic boosters" and "thyroid alternatives for weight management."

In pharmaceutical development, 3-Iodothyroacetic Acid serves as a valuable lead compound for structure-activity relationship studies. Medicinal chemists frequently modify its structure to create analogs with enhanced specificity or reduced side effects—a process known as rational drug design. The iodine atom's presence at the 3-position provides a convenient handle for further chemical modifications, while the acetic acid moiety offers opportunities for salt formation to improve solubility characteristics. These features make it a versatile scaffold in drug discovery programs.

Quality control and analytical characterization of 3-Iodothyroacetic Acid (CAS No. 60578-17-8) require specialized techniques due to its unique chemical properties. High-performance liquid chromatography (HPLC) with UV detection is commonly employed for purity assessment, while mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy provide structural confirmation. These analytical considerations are crucial for researchers, as compound purity directly impacts experimental reproducibility—a growing concern in life sciences, reflected by increasing searches for "research compound quality standards."

Environmental and stability considerations for 3-Iodothyroacetic Acid warrant special attention in research settings. The compound's sensitivity to light and temperature requires specific storage conditions, typically in amber vials at controlled temperatures. These handling requirements highlight the importance of proper laboratory protocols when working with biologically active compounds—a topic of increasing importance as evidenced by searches for "lab compound stability guidelines." Researchers must also consider appropriate disposal methods for iodinated compounds to minimize environmental impact.

Future research directions for 3-Iodothyroacetic Acid may explore its potential in personalized medicine approaches. With growing interest in precision endocrinology and individualized hormone therapies, this compound's unique properties could make it valuable for tailored treatment strategies. Additionally, its potential applications in age-related metabolic decline and cognitive preservation represent promising avenues for investigation—topics that resonate with an aging population increasingly searching for "healthy aging solutions" and "cognitive longevity strategies."

In conclusion, 3-Iodothyroacetic Acid (CAS No. 60578-17-8) represents a fascinating intersection of basic science and translational potential. Its unique biochemical properties continue to reveal new insights into thyroid hormone action while offering promising avenues for therapeutic development. As research progresses and public interest in thyroid-related health grows, this compound will likely remain at the forefront of endocrine research and innovative drug discovery efforts.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)